Year archive

Apontis Pharma AG — 2021 filings

All 24 regulatory filings released by Apontis Pharma AG (APPH) in 2021, sourced directly from the official regulator.

24 Filings

2021 Period

2021 filings (24)

Filing	Released	Lang
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO Board/Management Information	2021-12-16	English
APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights Regulatory Filings	2021-12-14	English
APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 - Revenue forecast increased Earnings Release 9M 2021	2021-11-18	English
9M Präsentation (EN) Investor Presentation	2021-11-18	German
9M Results Presentation Investor Presentation	2021-11-18	English
APONTIS PHARMA announces market launch of new Single Pill Regulatory Filings	2021-10-26	English
APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia Regulatory Filings	2021-09-14	English
APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figures and forecast confirmed Earnings Release H1 2021	2021-08-11	English
H1 Präsentation (EN) Investor Presentation H1 2021	2021-08-11	German
H1 Results Presentation Investor Presentation H1 2021	2021-08-11	English
Half-yearly financial statements 2021 Interim / Quarterly Report H2 2021	2021-08-11	German
APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 14.0 million Earnings Release H1 2021	2021-07-28	English
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy Regulatory Filings	2021-07-12	English
Annual financial statements 2020 Annual Report FY 2020	2021-06-28	German
APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 135% Regulatory Filings	2021-06-18	English
APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option Regulatory Filings	2021-06-10	English
APONTIS PHARMA AG: Notification on the implementation of stabilization measures Capital/Financing Update	2021-06-10	English
APONTIS PHARMA AG: Notification on the implementation of stabilization measures Share Issue/Capital Change	2021-05-28	English
APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues in the first four months of 2021 Earnings Release Q1 2021	2021-05-20	English
APONTIS PHARMA AG: Notification on the implementation of stabilization measures Capital/Financing Update	2021-05-19	English
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share Capital/Financing Update	2021-05-06	English
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share Capital/Financing Update	2021-05-06	English
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share Share Issue/Capital Change	2021-04-29	English
APONTIS PHARMA plans initial public offering Capital/Financing Update	2021-04-21	English